DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Lake Street Capital Markets Downgrades DermTech Inc. (DMTK) to Hold
April 19, 2024 7:29 AM EDTLake Street Capital Markets analyst Thomas Flaten downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Hold with a price target of $0.63.
For an analyst ratings summary and ratings history on DermTech Inc. click here. For more ratings news on DermTech Inc. click here.
Shares of DermTech Inc. closed at $0.59 yesterday.
... MoreBTIG Downgrades DermTech Inc. (DMTK) to Neutral
April 19, 2024 6:03 AM EDTBTIG analyst Sung Ji Nam downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Neutral.
The analyst comments "After the market close, DermTech announced that it has initiated a formal strategic review process. DMTK will consider all strategic options, including an acquisition, merger, reverse merger, business combination, licensing, sale of assets, or other transaction. In addition, DMTK announced it is again reducing its workforce, this time by 56%, or by ~100 employees. We spoke to the company following its... More
